DRTSW — Alpha Tau Medical Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1871321 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -13,782,000 | -45,813,000 | 134,250,000 | 22,993,000 | 90,195,000 |
| Mar 2026 | 0 | — | -13,313,000 | -22,939,000 | 108,773,000 | 4,636,000 | 39,421,000 |
| Dec 2025 | 0 | — | -12,602,000 | -12,136,000 | 105,652,000 | 12,202,000 | 28,553,000 |
| Sep 2025 | 0 | — | -10,730,000 | -11,686,000 | 104,694,000 | 3,329,000 | 27,110,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-258,888,000
Inventory
—
Receivables
$2,059,000
ST Investments
$77,646,000
EBIT TTM
$-92,039,000
Pretax Income TTM
$-92,399,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -42,288,000 | -42,627,000 | 105,652,000 | 28,553,000 | 77,099,000 | -26,681,000 |
| Dec 2024 | 0 | -36,042,000 | -31,750,000 | 86,204,000 | 23,538,000 | 62,666,000 | -19,783,000 |
| Dec 2023 | 0 | -35,680,000 | -29,157,000 | 107,388,000 | 22,913,000 | 84,475,000 | -17,958,000 |
| Dec 2022 | 0 | -32,136,000 | -33,762,000 | 120,149,000 | 14,492,000 | 105,657,000 | -23,879,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | $152.10B | $430.53 | — |
| MDT | Medtronic plc | $130.88B | $102.32 | — |
| SYK | STRYKER CORP | $120.88B | $317.54 | — |
| MMM | 3M CO | $93.28B | $180.88 | — |
| BSX | BOSTON SCIENTIFIC CORP | $62.37B | $43.03 | — |
News headlines (Yahoo Finance, 1h cache)
How Investors May Respond To Alpha Tau Medical Stock After Glioblastoma Trial Results
2026-11-18 01:10 · Yahoo
Alpha Dart Therapy Shows Complete Tumor Clearance in Five Brain Cancer Patients
2026-11-16 14:37 · Yahoo
Alpha Tau Announces New Positive Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial: All Patients Treated are Alive with Median Survival Not Reached, 6.9 Months Median Follow-Up in
2026-11-15 18:00 · Yahoo
Buy Alert: 5 Stocks Analysts Upgraded on Wednesday
2026-11-13 21:12 · Yahoo
Alpha Tau to Host Investor Call to Review New Data from the Alpha DaRT® Recurrent Glioblastoma REGAIN Trial
2026-11-12 13:30 · Yahoo
Nvidia downgraded, Mercury Systems upgraded: Wall Street's top analyst calls
2026-11-11 14:45 · Yahoo
Alpha Tau Medical (DRTS) Stock May Be Hard To Justify Despite Its 343% Run
2026-11-07 01:12 · Yahoo
Alpha Tau Announces Inclusion in the Flagship TA-90 and TA-125 Indices of the Tel Aviv Stock Exchange
2026-10-29 16:14 · Yahoo
Alpha Tau and Samsung Medical Center Sign MOU to Explore Clinical Trial of Alpha DaRT® for Pancreatic Cancer Patients in Korea
2026-10-22 12:30 · Yahoo
How Investors Are Reacting To Alpha Tau Medical (DRTS) Expanded Brain Cancer Trial
2026-10-21 01:18 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.